SungWan Chun

4PUBLICATIONS
38CO-AUTHORS
PharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)Experimental economics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Dec 19, 2025
Efficacy and safety of combining empagliflozin in people with type 2 diabetes mellitus uncontrolled with metformin and sitagliptin: A randomised, double-blind, multicentre, therapeutic confirmatory phase 3 clinical trial.

Seung-Hwan Lee, Kyung Ah Han, Eun-Gyoung Hong

|Aug 14, 2025
Efficacy and safety of pioglitazone, empagliflozin and glimepiride as third-line agents in patients with type 2 diabetes inadequately controlled with metformin and DPP-4 inhibitors: A multicentre, phase 4 randomized controlled trial.

Yun Kyung Cho, Jae-Hyoung Cho, Sang-Mo Hong

|Jul 29, 2025
Efficacy and safety of lobeglitazone added to metformin and sitagliptin combination therapy in patients with type 2 diabetes: A 52-week, multicentre, randomized, placebo-controlled, phase III clinical trial.

Eun-Gyoung Hong, Kyung-Wan Min, SungWan Chun

|Jul 26, 2024
Long-term efficacy and safety of enavogliflozin in Korean people with type 2 diabetes: A 52-week extension of a Phase 3 randomized controlled trial.

Soo Heon Kwak, Kyung Ah Han, Eun Sook Kim

Pageof 1

Frequent Collaborators

2 joint publications

Seungjoon Oh

2 joint publications

Kyung Ah Han

2 joint publications

Eun-Gyoung Hong

2 joint publications

Chong Hwa Kim